tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
TBPH is currently covered by 3 analysts with an average price target of $21.18. This is a potential upside of $6.88 (48.11%) from yesterday's end of day stock price of $14.3.
Theravance Biopharma's activity chart (see below) currently has 80 price targets and 60 ratings on display. The stock rating distribution of TBPH is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 48.82% with an average time for these price targets to be met of 308.58 days.
Highest price target for TBPH is $15, Lowest price target is $15, average price target is $11.33.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 27-Feb-2025. First documented stock forecast 03-Feb-2015.
Currently out of the existing stock ratings of TBPH, 3 are a HOLD (33.33%), 6 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$0.7 (4.90%)
$15
6 months 18 days ago
(27-Feb-2025)
4/16 (25%)
$5.73 (61.81%)
343
Hold
$9
$-5.3 (-37.06%)
$10
1 years 1 months 8 days ago
(06-Aug-2024)
5/6 (83.33%)
$1.17 (14.94%)
371
Hold
$10
$-4.3 (-30.07%)
$14
1 years 1 months 8 days ago
(06-Aug-2024)
3/3 (100%)
$2.17 (27.71%)
776
Sell
$10
$-4.3 (-30.07%)
$10
3 years 1 months 20 days ago
(25-Jul-2022)
3/8 (37.5%)
$0.76 (8.23%)
538
Buy
$12
$-2.3 (-16.08%)
3 years 3 months 22 days ago
(23-May-2022)
4/8 (50%)
$2.6 (27.66%)
358
What is TBPH (Theravance Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on TBPH (Theravance Biopharma) with a proven track record?
Which analyst has the most public recommendations on TBPH (Theravance Biopharma)?
Which analyst is the currently most bullish on TBPH (Theravance Biopharma)?
Which analyst is the currently most reserved on TBPH (Theravance Biopharma)?
